ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,815,860 | +8.0% | 22,000 | -14.4% | 5.89% | +11.4% |
Q2 2023 | $10,016,061 | +4.6% | 25,700 | 0.0% | 5.29% | -9.7% |
Q1 2023 | $9,575,310 | +1.1% | 25,700 | +2.8% | 5.86% | -8.4% |
Q4 2022 | $9,470,750 | +7.3% | 25,000 | 0.0% | 6.40% | +12.3% |
Q3 2022 | $8,826,000 | -6.8% | 25,000 | 0.0% | 5.70% | +1.1% |
Q2 2022 | $9,472,000 | +20.2% | 25,000 | 0.0% | 5.64% | +63.3% |
Q1 2022 | $7,883,000 | -10.0% | 25,000 | 0.0% | 3.45% | -2.7% |
Q4 2021 | $8,755,000 | +16.0% | 25,000 | 0.0% | 3.55% | +6.5% |
Q3 2021 | $7,550,000 | +25.4% | 25,000 | +25.0% | 3.33% | +56.3% |
Q2 2021 | $6,021,000 | -8.9% | 20,000 | -16.7% | 2.13% | -25.8% |
Q1 2021 | $6,609,000 | -6.4% | 24,000 | 0.0% | 2.87% | -1.3% |
Q4 2020 | $7,058,000 | +12.0% | 24,000 | 0.0% | 2.91% | -9.6% |
Q3 2020 | $6,300,000 | +16.5% | 24,000 | 0.0% | 3.22% | +6.5% |
Q2 2020 | $5,406,000 | +71.0% | 24,000 | 0.0% | 3.02% | +46.2% |
Q1 2020 | $3,162,000 | -10.5% | 24,000 | +9.1% | 2.07% | -7.5% |
Q4 2019 | $3,531,000 | – | 22,000 | – | 2.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |